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Lifestyle information and access to commercial weight management groups to support maternal 1 
postnatal weight management to 12 months: the SWAN feasibility RCT 2 
Abstract  3 
Objectives: To assess feasibility of a future randomised controlled trial (RCT) of clinical and cost-4 
effectiveness of lifestyle information and commercial weight-management groups to support 5 
postnatal weight management to 12 months post-birth.  6 
Design: Two-arm feasibility trial, with nested mixed-methods process evaluation. 7 
Setting: Inner-city unit, South England. 8 
Population:  Women with BMIs ≥25kg/m2 at pregnancy booking or normal BMIs (18.5kg/m2-9 
24.9kg/m2) identified with excessive gestational weight gain  at 36 weeks gestation.  10 
Methods:  Randomised to standard care plus commercial weight-management sessions commencing 11 
8-16 weeks postnatally or standard care only. 12 
Main outcomes:  Feasibility outcomes included assessment of recruitment, retention, acceptability, 13 
and economic data collation. Primary and secondary endpoints  included difference between groups 14 
in weight 12 months postnatally compared with booking (proposed primary outcome for a future 15 
trial), diet, physical activity, smoking, alcohol, mental health, infant feeding, NHS resource use. 16 
Results: 193 women were randomised; 98 intervention and 95 control; only four women had excessive 17 
gestational weight gain. A slightly greater weight change was found among intervention women at 12 18 
months, with greatest benefit.  among women attending 10+ weight management sessions.  There 19 
was >80% follow-up to 12 months, low risk of contamination and no group differences in trial 20 
completion. 21 
Conclusion: It was feasible to recruit and retain women with BMIs≥25kg/m2 to an intervention to 22 
support postnatal weight management; identification of excessive gestational weight gain requires 23 
consideration. Economic modelling could inform out-of-trial costs and benefits in a future trial. 24 
A definitive trial is an important next step.  25 
Funding: NIHR Public Health Research Programme 14/67/14 26 
Key words: Postnatal, weight management, randomised controlled trial, feasibility 27 
Trial registration: This trial is registered as ISRCTN 39186148  28 
Protocol: https://njl-admin.nihr.ac.uk/document/download/2012000  29 
Tweetable abstract 30 
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A feasibility RCT of postnatal weight support showed women with BMIs≥25kg/m2 can be recruited 31 
and followed to 12 months postnatally  32 
 33 
  34 
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Introduction  35 
 36 
At six to eight weeks postnatally, two thirds of women have a higher weight than before pregnancy1, 37 
with postpartum weight retention contributing to poorer long-term health2,3 and failure to 38 
breastfeed4,5. There is limited evidence for pregnancy-specific weight management interventions6,7,8.  39 
A meta-analysis of individual participant data of diet and physical activity interventions9 reported less 40 
gestational weight gain in intervention than control groups, but no significant reductions in other 41 
outcomes of interest. 42 
 43 
The USA Institute of Medicine defines clinically significant weight loss in the general population as ≥5% 44 
of initial weight within 6 months of the intervention, a reduction associated with fewer weight 45 
morbidities10, although smaller weight loss may result in health gains11. A Cochrane review of diet 46 
and/or exercise for postnatal weight reduction12 found exercise alone was not effective (two trials, 47 
n=53, mean difference -0.10kg, 95% CI -1.90 to 1.71), but diet (one trial, n=45, mean difference -48 
1.70kg, 95% CI -2.08 to -0.132) or diet plus exercise (seven trials, n=573, mean difference -1.93kg, 95% 49 
CI -2.96 to -0.89) was effective.   Data were insufficient to infer other potential risks or benefits for 50 
women or infants12. 51 
 52 
Interventions to reduce postpartum weight retention across all BMI categories have included 53 
counselling, individualised physical activity plans, healthy eating groups, and clinic visits. In one 54 
systematic review, seven of 11 trials found a decrease in weight retention, six including diet and 55 
physical activity interventions2.  No study considered cost-effectiveness, with wide heterogeneity in 56 
approaches to intervention implementation. Dalrymple et al (2018)13 reviewed lifestyle interventions 57 
in overweight and obese women for postpartum weight management. Seven postpartum-only 58 
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interventions showed significant improvements in weight compared with controls, suggesting 59 
potential for weight management.  60 
 61 
A general population study of individuals with obese or overweight BMIs (N=740) indicated that 62 
commercial weight loss programmes (where where an individual can choose from a range of options 63 
and providers to suit their lifestyle and budget, including group or online interventions) may be more 64 
beneficial than healthcare-based programmes (which may include a prescribed programme of 65 
contacts with a clinician in a healthcare setting) 14.  Commercial weight programmes achieved better 66 
weight loss at programme end (mean difference 2.3kg (1.3 to 3.4kg) and were approximately £40 67 
cheaper per person than primary care services. 68 
 69 
This single centre, two-arm individually randomized feasibility trial with a nested mixed-methods 70 
process evaluation assessed feasibility of conducting a future definitive RCT to determine 71 
effectiveness and cost effectiveness of lifestyle information and access to a commercial weight 72 
management group (Slimming World® (Alfreton, UK)) to support longer-term postnatal weight 73 
management and positive lifestyle behaviour in women at risk of poor weight management.  74 
 75 
Methods  76 
Participant eligibility 77 
Women 18 years and over, speaking and reading English, with a singleton pregnancy who had not 78 




Recruitment, from one inner-city maternity unit, reflected two approaches: 1) Women with BMIs 81 
≥25kg/m2 identified from antenatal booking information;  at 26 weeks gestation, women were sent a 82 
letter advising a Research Midwife (RM) would contact them, which also explained how the woman 83 
could contact the RM if she did not want to receive further information.  Two weeks later, the RM 84 
contacted women who had not asked to be removed from the contact list, to explain the study; 2) 85 
Women with healthy BMIs at antenatal booking who gained more weight than recommended by IOM 86 
guidelines10 could self-refer, or be referred by clinicians, to RMs to be weighed at 36 weeks’ gestation 87 
(routine weighing is not recommended in NHS antenatal care15).  As this approach did not succeed, 88 
the protocol was revised to send letters to all women with normal booking BMIs who were 32-34 89 
weeks gestation, inviting them to be weighed for excessive gestational weight gain  at 36 weeks 90 
gestation.   91 
 92 
All women received a Patient Information Sheet (PIS) prior to seeking written informed consent from 93 
those who agreed to participate at 36 weeks gestation.   94 
 95 
Intervention  96 
Women received standard care (see below), plus a lifestyle information leaflet with evidence-97 
informed guidance on breastfeeding, diet,  smoking cessation, reducing alcohol and managing 98 
sleep16,17 and access to a commercial weight management programme (Slimming World®, Alfreton, 99 
UK) for 12 weekly sessions, commencing anytime from 8-16 weeks postnatally. Women could choose 100 
which group they attended and when they started, to accommodate birth recovery, lifestyle and 101 




Slimming World® (Alfreton, UK) groups are homogeneous in content and delivery18, promoting key 104 
behaviour change techniques including goal setting, social support and positive reinforcement, 105 
underpinned by social cognitive theory relevant to motivation and self-efficacy for weight 106 
management19,20. A food optimising system encourages healthy eating, recommending that 80% of 107 
foods are fruit, vegetables, and satiating foods (carbohydrates and protein); alongside measured 108 
portions of fibre and calcium-rich foods; and an allowance for foods high in fat or sugar.  The plan is 109 
designed to be unrestrictive and adaptable to cultural and dietary preferences, and includes guidance 110 
for breastfeeding women to ensure key nutritional requirements are met. A ‘Body Magic’ programme 111 
promotes importance of physical activity. 112 
 113 
Women were offered (fees waived) attendance for 12 sessions over 14 consecutive weeks, allowing 114 
two ‘holiday’ weeks.  To achieve 5% weight loss from baseline, a difference considered to improve 115 
health outcomes (Donnelly et al 2009)21, attending at least 10 sessions is recommended19.   116 
 117 
Control group 118 
Standard NHS maternity care to six-eight weeks postpartum, including routine midwife, health visitor 119 
and GP contacts.   120 
 121 
Randomisation 122 
Individual participants were randomly allocated in ratio of 1:1 to intervention or control using a web-123 
based system developed by King’s Clinical Trials Unit, with relevant data entered by the RM.  Intention 124 
to treat (ITT) analysis limited attrition and analytical bias. It was not possible to ‘blind’ RMs or women 125 





Progression criteria  129 
Progression criteria included recruitment uptake, time to complete recruitment; retention of women 130 
to 12 months postnatally, acceptability of study procedures and intervention, contamination between 131 
study groups, and if relevant data could be collated to inform an economic evaluation. 132 
 133 
Primary and secondary feasibility outcomes 134 
The primary feasibility outcome, to inform the effect size for a definitive trial, was difference between 135 
study groups in weight 12 months postnatally, expressed as % weight change and weight loss from 136 
documented antenatal-booking weight.  A core outcome set was not used. 137 
   138 
Secondary outcomes were selected as appropriate to inform progress to a definitive RCT.  These 139 
included rates of 5% and 10% weight reduction and changes in relation to healthy lifestyle and health 140 
behaviours. The following were used: 141 
 Dietary Instrument for Nutritional Education (DINE© University of Oxford)22 ] 142 
 International Physical Activity Short-Form23 143 
 Edinburgh Postnatal Depression Scale*24 144 
 Smoking status/cigarette dependence25 145 
 Alcohol Use Disorders Identification Test26 146 
 Rosenberg Self-Esteem Scale27 147 
 Impact on body image*28 148 
 EQ-5D-5L29 149 
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 Soft drink intake; breastfeeding intent, uptake and duration; sleep patterns*; infant health*: 150 
questions developed for the feasibility study 151 
 Adult Service Receipt Schedule (AD-SUS)30 152 
*included at six & 12 months 153 
 154 
At six and 12 months, all women were asked about the timing and type of postnatal weight support 155 
they had accessed to assess potential contamination, and inform future decisions about timing of 156 
commencement of the intervention offer.  An integral mixed-methods process evaluation examined 157 
the acceptability of the intervention and study procedures. These findings are reported separately.  158 
 159 
Patient and public involvement 160 
A group of four local women who had experienced previous pregnancies with BMIs of ≥25kg/m2were 161 
convened at study development to advise the team on approaches to recruitment, intervention and 162 
outcomes most likely to be of importance to postnatal women.  This group met regularly throughout 163 
the study period.  VB co-ordinated the PPI group on behalf of the SWAN trial team.  164 
 165 
 166 
Data collection 167 
Information at trial entry, including eligibility, booking BMI, parity, age, ethnicity, deprivation score, 168 
total household income, birth mode, gestation, birthweight and inpatient stay were obtained from 169 
maternity records.  The baseline questionnaire was completed at recruitment (36 weeks gestation).  170 
At six and 12 months women met with RMs to be weighed and complete questionnaires.  If women 171 




Sample size 174 
The proposed sample size was 190, allowing 30% loss to follow up to achieve data from 130 women 175 
at 12 months post-birth and inform estimates of required sample size for any clinically important 176 
differences to within 30% of true value. The mean (SD) percentage weight change following Slimming 177 
World’s programme of 12 weekly groups is -5.5%, (3.3)18. Assuming numbers were typical, 65 women 178 
in each group were required to detect a difference of 2% between intervention and control arms with 179 




Recruitment was assessed as number of women randomised per month, with 95% confidence 184 
intervals derived from the Poisson distribution, and retention as proportion of women randomised 185 
providing analysable data for primary assessment at 12 months.  Linear regression was used for the 186 
primary endpoint and other continuous measures. Adjustment was made for corresponding 187 
measurements made pre-randomisation31.  Binary regression with a log-link was used to assess risk 188 
ratios for all binary outcomes, adjusting for maternal age, BMI, ethnicity, and parity.  Following 189 
CONSORT and other recommendations32, risk differences were also estimated. Significance tests were 190 
only conducted to test for differences in dropout rates between groups, and estimates of treatment 191 
effects.   192 
 193 
For primary analysis, participants were analysed in the groups into which they were randomly 194 
allocated. Estimated differences and 95% Confidence Intervals were calculated for specified primary 195 
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and secondary analyses (significance at 5%). Sensitivity analyses were used to assess robustness of 196 
conclusions to missing outcome data and departures from randomized treatment 197 
 198 
Reduction of weight by more than 5% and 10% at six and 12 months were analysed as binary variables, 199 
with health ratios and risk differences presented.  Sub-group analysis of the primary endpoint among 200 
overweight (BMI 25–29.9 kg/m²) and obese (BMI ≥30 kg/m²) women was pre-planned, with 201 
interaction tests to determine if treatment effect varied by sub-group.  202 
 203 
To explore if women who attended 10+ sessions had greater 12-month weight loss than women 204 
attending nine or fewer, or control women, or if women who documented their own weight in 205 
questionnaires had different weight change than women who attended appointments, subgroup 206 





Ethical approval 212 
Approval was granted by Health Research Authority London – Camberwell St Giles REC on 2nd 213 
September 2016 (reference:16/LO/1422) and HRA approval on 11th October 2016.  214 
 215 
Results  216 
Recruitment and retention 217 
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Between November 2016 and July 2017, of 1132 women potentially eligible, 835 (73.5%) were not 218 
recruited, 59 (5.2%) were later ineligible (e.g., had a premature birth), and contact data on 43 (3.8%) 219 
women were missing from their records.  In most cases, study letters were returned unopened or 220 
phone calls not returned.  Women who were contacted and asked why they would not consider 221 
recruitment reported practical barriers, such as moving house, or not having any concerns about their 222 
weight.  Of 195 (17.2%) women who agreed to attend the recruitment appointment, two changed 223 
their minds; 193 were recruited and randomised, 97% of whom had BMIs >25kg/m2. Only four of nine 224 
women with a healthy BMI at booking who responded to a study letter and met the RMs at 36 weeks 225 
gestation had EGWG and were eligible to participate.  226 
 227 
The CONSORT diagram (Figure 1), shows trial participant flow.  Two women withdrew, one from the 228 
control at six month follow-up, and one from the intervention at 12 months.  Neither asked for data 229 
to be withdrawn.  Only women who returned a six month questionnaire were sent a 12 month 230 
completed a questionnaire, 20 women returning a copy by post; at 12 months, 69/83 (83.1%) 231 
intervention and 71/75 (94.6%) control women completed questionnaires; 32 returned by post.  232 
 233 
Baseline characteristics  234 
Antenatal booking BMI data informed study outcome comparisons.  Customised birthweight centiles33 235 
included correction for expected birthweight for maternal height, weight, ethnicity, parity, neonatal 236 
gender and gestation at delivery (Table 1).  237 
 238 
Mean maternal age was 32 (SD=5.2), and mean maternal booking BMI 30.51kg/m2 (SD=5.4) (Table 1). 239 
More intervention women had a mean BMI ≥30 kg/m2 at booking and twice as many had planned 240 
caesarean section compared with controls. Mean gestational birth age was 39.4 weeks (SD=2.5), and 241 
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mean infant birthweight 3.43kgs (SD=503). Most women lived in areas of highest social deprivation34, 242 
although a third of women had total household incomes of ≥£61k.  A slightly lower proportion of white 243 
women were recruited compared with the local maternity population, with a slightly higher 244 
proportion of Black women35.  Differences between groups at baseline were not assessed 245 
statistically36. 246 
 247 
Proposed primary and secondary outcomes  248 
After adjusting the most powerful predictors measured pre-randomization, using linear regression and 249 
removing any biases due to chance imbalance at baseline, weight loss at 12 months postnatally was 250 
greater than at six months (Table 2), supporting 12 months as a future primary endpoint.  251 
 252 
Pre-planned sub-group analysis of various secondary endpoints showed no significant differences 253 
between the intervention and control group (Table 3). ).  There was no evidence of differences in 254 
weight outcomes among women with higher BMIs who self-reported or were weighed by RMs.  255 
  256 
Of the 98 intervention women, 46 (47%) attended one or more weight management sessions. Based 257 
on per-protocol analysis, women who attended 10+ sessions (19/46, 41%) had greater weight loss at 258 
12 months than women who attended nine or fewer sessions or none at all, or were control group 259 
(95% CI 1.05 to 8.93, p0.013).  260 
 261 
There was no evidence of differences between groups and  dietary intake, physical activity, body 262 




With respect to other secondary outcomes, differences if present were only detected at six months. 265 
Intervention women were more likely to be drinking diet or sugar-free squash than control women 266 
(OR 2.84, 95% CI 1.11 to 7.29, p=0.029), with no differences at baseline or 12 months (Table S8, 267 
appendices).  They were also more likely to have EPDS scores ≥12 at six months, indicating possible 268 
depression (intervention, 9/83 (10.8%), control 1/75 (1.3%), RR=8.13 (1.06 to 62.69), p=0.01) (Table 269 
S9, appendices) and less likely to drink any alcohol than control women at six months (44/53.0% ‘v’ 270 
33/44.6; p=0.038, 95% CI -2.719 to -0.083), but not at baseline or 12 months (Table S10, appendices).   271 
 272 
At six months, most women (95%) reported that they had breastfed (Table S11), although more 273 
control women exclusively breastfed.   At 12 months, over a third continued to breastfeed.  Women 274 
introduced their infants to solid foods at a mean age of 22.2 (SD=3.72) weeks in the intervention and 275 
23.4 (SD=4.78) the control.  Intervention women stopped breastfeeding earlier than control (20.0 276 




Acceptability of trial processes and intervention 281 
There was low risk of contamination; only five control women joined Slimming World and a further 282 
four joined a similar commercial programme.  In total, 25/83 (30%) intervention and 28/75 (37%) 283 
control women accessed additional weight management support at six months, with similar rates at 284 
12 months.  Most control women accessed support five to six months postnatally. Joining a gym was 285 





There was little or no difference in trial completion between groups (Difference -2.2%, 95% CI -15.2 289 
to 10.8), and responses to measures showed high overall completion (>80%, Table S12).    290 
 291 
 292 
Of 46/98 (47%) intervention women who attended at least one Slimming World®(Alfreton, UK) 293 
session, most accessed the support after 10 weeks postnatal and mean number of sessions attended 294 
was 6.74 (SD=3.94).  Most women continued with the same group they started with.  Of the 52 women 295 
who did not attend, of 39 (75%) providing reasons, most described “opportunity” or “motivation” 296 
issues, including that it was too soon after birth, or did not recognise they had a weight problem.  297 
 298 
 299 
Health Economics  300 
Selected economic data collection tools to collate information from women’s questionnaires and 301 
maternity records, were suitable as a basis for an evaluation of cost-effectiveness in a definitive trial.  302 
 303 
Discussion  304 
Main findings 305 
It was possible to recruit and retain women with BMIs≥25kg/m2 to this feasibility RCT, although 306 
approaches to recruit women with excessive gestational weight gain  were not successful.   307 
Intervention women had greater weight loss at 12 months, with evidence of a ‘dose effect’ in terms 308 
of number of sessions attended, with minimal impacts on other lifestyle behaviours. It was feasible to 309 
combine women’s self-report and maternity record data to evaluate within-trial economic impacts.  310 
We aimed to recruit 190 women over six months, and recruited 193 women over eight months, the 311 
additional time reflecting protocol revisions to identify and recruit women with excessive gestational 312 
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weight gain.  A high number of potentially eligible women did not respond to contacts, which could 313 
reflect a number of issues, including that women had too many other commitments during pregnancy, 314 
or did not want to consider postnatal weight management support, but high follow up rates of women 315 
who were recruited were reassuring.   316 
 317 
Our findings provide some support for using measurements at 12 months, rather than six months, 318 
which our PPI group agreed with. .  The difference  in weight was slightly greater at 12 months than at 319 
six months among intervention women. If real, this may be because some women had not yet received 320 
the full intervention at six months, but could reflect the need for women to have longer access to fully 321 
adapt to the weight management programme.  This would support findings of a general population 322 
trial where individuals allocated to a 52 week open group weight management programme had 323 
greater weight loss over a two year period than those randomised to a 12 week programme or 324 
received brief advice and self-help materials.37  325 
 326 
Secondary outcomes showed minimal differences. Those which were found (e.g., higher EPDS scores 327 
at six months among intervention women) are important to consider further in future research given 328 
evidence of physical and psychological co-morbidity in this population38. Few intervention women 329 
recalled the lifestyle information leaflet offered at recruitment, but for women in late pregnancy/early 330 
postnatal period it was unlikely that healthy lifestyle advice was an immediate priority.  For a definitive 331 
trial, providing additional information alongside weight management support, would have to be 332 
considered, including optimal format of dissemination. 333 
 334 
There was an apparent dose-response effect on weight outcomes, with greatest benefit found among 335 
women who attended 10+ Slimming World®(Alfreton, UK) sessions.  A higher uptake would have been 336 
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encouraging, however, as the sample included women from an inner-city area with childcare and 337 
other responsibilities, who may not have encountered a similar weight management intervention 338 
before, that just under half attended at least one session could be viewed positively. Previous trials 339 
have reported similar uptake of weight management interventions among those in high and low-340 
income areas39, with potential for targeted schemes to support weight management among adults 341 
living in areas of higher social deprivation.   Process evaluation findings will inform uptake and 342 
retention strategies for a future trial. 343 
 344 
It was feasible to generate economic data using participant self-report information and maternity 345 
records.  346 
 347 
Strengths and limitations 348 
We could recruit pregnant women with high BMIs from diverse ethnic backgrounds living in an inner 349 
city area, and follow to 12 months postnatally.  Women completed a broad range of health outcome 350 
measures, with no apparent problems with data completion.  Intervention group women could access 351 
sessions at a venue, day and time to suit needs and lifestyles, an issue our PPI group considered of 352 
high importance to support women who had recently given birth.  The programme is standardised 353 
and evidence-based18 and suitable for new mothers, including those who were breastfeeding. 354 
   355 
For a future trial, we have evidence of how to potentially increase uptake of the intervention, including 356 
extending the duration of ‘offer’ and providing more information about the programme following 357 
group allocation.  Women were willing to meet the RMs at the two scheduled follow up contact points, 358 
indicating that this approach will support high data completion in a future trial.  PPI support and advice 359 
as the trial progressed enabled any ongoing issues to be quickly addressed and resolved.     360 
18 
 
Economic modelling to inform longer-term impacts on outcomes of importance may be warranted in 361 
a future trial.  362 
 363 
Limitations included being unable to identify and recruit women with excessive gestational weight 364 
gain, meaning findings are only relevant to women with BMIs >25kg/m2.   That some measures had 365 
not been validated in a postnatal population means validity and interpretation cannot be confirmed. 366 
As a single centre feasibility study, findings may not be generalised. 367 
 368 
Interpretation in light of other evidence 369 
This is one of the first UK studies to consider a specific postnatal weight management intervention.  370 
The importance of postnatal intervention is becoming clearer, given concerns about longer-term 371 
impacts of maternal obesity, and lack of evidence of effectiveness of pregnancy-only interventions7,8. 372 
A recent review of reviews again showed interventions involving physical activity and/or dietary 373 
changes could be effective in managing postnatal weight, although findings should be interpreted with 374 
caution due to statistical heterogeneity39. 375 
 376 
As women with higher BMIs experience a range of persistent co-morbidity, such as diabetes and 377 
hypertensive disorders40,41, the timing and content of a postnatal weight management intervention 378 
has to reflect birth recovery, demands of parenthood, potential return to employment, social 379 
circumstances and mobility of the population.   This study shows that women who were interested in 380 
weight management support were willing to participate and complete the study, but approaches have 381 
to be flexible and reflect each woman’s decision about when she feels timing of an intervention is 382 




Failure to recruit women with excessive gestational weight gain  suggests these women will remain 385 
‘under the radar’, with implications for life-course health. UK guidance15 is that women should not be 386 
weighed routinely.  Even contacting women directly did not identify a large number who met IoM 387 
criteria for EGWG at 36 weeks. The potential to inform lifestyle behaviours was less clear, but could 388 
reflect positive lifestyle behaviours, such as high breastfeeding uptake in our local population35 (no 389 
data on longer-term rates were available locally).  Integration of evidence, and discussion of findings 390 
with our PPI group, highlighted several key findings to optimise intervention uptake in a definitive 391 
study, including offering more information about the intervention in pregnancy, a longer 392 
commencement period, and alternative approaches to presenting information on positive health 393 
behaviours.   394 
 395 
Inclusion of economic modelling of longer-term impacts could prove an essential vehicle for a more 396 
complete and robust examination of programme cost-effectiveness 397 
Conclusion 398 
Most feasibility objectives were achieved.  Process evaluation findings indicate that if commercial 399 
weight management sessions are to support women with higher BMIs to achieve and sustain postnatal 400 
weight loss and adapt positive lifestyle change, a wider window of commencement should be offered 401 
and the duration of the intervention extended.  An online intervention arm could counteract some 402 
‘opportunity’ issues identified by women for not attending sessions, but evidence of effectiveness of 403 
such formats is needed. As economic impacts over the course of a short-term trial are unlikely to 404 
demonstrate cost-effectiveness of weight management longer-term for women and their infants, a 405 




Women who participated may have been more motivated and interested, but once recruited, follow 408 
up and adherence was good.  A further larger trial of effectiveness of lifestyle information and 409 
commercial weight management groups is an important next step to consider how best to support 410 
weight management among women with higher BMIs who have recently given birth. 411 
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Table 1. Baseline characteristics on all women randomised. 
* EGWG : Excessive gestational weight gain, IoM criteria, ** Ethnicity based on UK census categories, 
***IMD: Index of Multiple Deprivation [48], **** Customised birthweight centiles [46], ^numbers 
are slightly reduced due to some missing values 
 
 
                    
Women’s characteristics Intervention                Control 
 Intervention (n= 98) Control (n= 95) 
Age (years)             32.44 (5.10)       33.06 (5.37)     
Height (m) 1.64 (0.07)            1.64 (0.06)       
Maternal weight   
Weight (kg) 83.77 (18.77)             80.53 (13.17)                    
Mean booking BMI 
(kg/m2) 
31.18 (6.47)               29.83 (4.11)                      
<25, no EGWG*                        0 (0.0%)                        1(1.1%) 
25-29.9, no EGWG                 2 (2.0%) 1(1.1%) 
25-29.9, EGWG                       20 (20.4%) 31(32.6%) 
30-34.9, no EGWG               37(37.8%) 26(27.4%) 
30-34.9, EGWG                     9(9.2%) 18(18.9%) 
35+, no EGWG                      14(14.3%) 11(11.6%) 
35+, EGWG                            11(11.2%) 6(6.3%) 
Ethnicity**   
White 38 (38.8%)             40 (42.1%)                                 
Black 40 (40.8%)             36 (37.9%)                    
Asian  6 (6.1%)               2 (2.1%)                                        
Other 14 (14.3%)          17 (17.9%)                                  
Total household income   
£0-£5,475 7 (7.1) 5 (5.2) 
£5,476-£15,000 11 (11.2) 9 (9.4) 
£16,000-£30,000 14 (14.2) 11 (11.5) 
£31,000-£45,000 8 (8.1) 10 (10.5) 
£46,000-£60,000 7 (7.1) 11 (11.5) 
£61,000+ 32 (32.2) 31 (32.6) 
Would not say 19 (19.3) 18 (19.1) 
IMD (centile scale)***^ 0.27 (0.15)                  0.28 (0.17)                               
IMD quintiles   
1 (least deprived)  2 (2.0%)               2 (2.2%)                                        
2 2 (2.0%)                        3 (3.2%)                                               
3 11 (11.2%)             15 (16.1%)                                          
4 49 (50.0%)         41 (44.1%)                                       
5 (most deprived) 34 (34.7%)             32 (34.4%)                                        
Gestation at birth (wks)   39.38 (1.54)      39.49 (3.36)                                     
Mode of birth^                    
Vaginal (normal) 45(46.4%) 53(56.4%) 
Vaginal (assisted) 10(10.3%) 12(12.8%) 
Planned C.section 30 (30.9%) 14(14.9%) 
Emergency C.section 10(10.3%) 14(14.9%) 
Birthweight**** 3378.14 (497.51)  3500.00 (505.90)  
<10th centile 14/90 (15.6%)          7/89 (7.9%)           
28 
 
<3rd centile 5/90 (5.6%)            2/89 (2.2%)          
 
 
Table 2. Average weights and weight changes at antenatal booking, trial entry, six and 12 months 
postnatally adjusted for baseline.  
* Differences in weight change are adjusted for weight at end of pregnancy, maternal age, parity, 562 





Table 3.  Weight reduction by more than 5% and 10% at six and 12 months postnatally 
  Intervention Usual Care Health Ratio 
(95% CI) 
Risk Difference (95% CI) 
Six months       
More than 5% weight 
reduction 
20/82 (24.4%) 10/72 (13.9%) 1.76 (0.88 to 
3.50) 
        10.5% (-1.8 to 22.8) 
More than 10% weight 
reduction 
6/82 (7.3%) 2/72 (2.8%) 2.63 (0.55 to 
12.64) 
4.5% (-2.3 to 11.3) 
12 months       
More than 5% weight 
reduction 
16/69 (23.2%) 18/71 (25.4%) 0.91 (0.51 to 
1.64) 
-2.2% (-16.4 to 12.0) 
More than 10% weight 
reduction 
9/69 (13.0%) 3/71 (4.2%) 3.09 (0.87 to 
10.93) 
8.8% (-0.4 to 18.0) 
 
 
                                             Intervention  Mean (SD)          Control Mean (SD)           Difference*  (95% CI) 
Baseline (n) 98 95  
Estimated antenatal weight 82.52 (18.77) 79.28 (13.17)  
Weight at start of pregnancy 
(kg) 
83.77 (18.77) 80.53 (13.17)  
Weight at end of pregnancy (kg) 94.04 (16.93) 89.31 (11.97)  
Six months postnatal (n) 82 72  
Weight (kg) 83.24 (17.68)     81.88 (12.60)  
Adjusted treatment effects    
6 months postnatal (n)** 80 71  
Weight change (kg) -8.74 (9.73)    -6.57 (6.43)     -1.66 (-4.49 to  1.16) 
Weight change (%) -9.56 (11.01)  -7.52 (7.24)    -1.83 (-5.06 to  1.41) 
12 months postnatal (n) 69 71  
Weight (kg)  82.35 (18.41) 81.89 (14.60)  
12 months postnatal (n)** 68 70  
Weight change (kg) -10.26 (8.24)     -7.50 (7.12)      -3.63 (-6.45 to -0.81)     
Weight change (%) -11.48 (8.96)     -8.65 (7.72)      -4.02 (-6.98 to -1.07)    
  
